CRNX
Crinetics Pharmaceuticals Inc.
$35.98
+$2.26(+6.70%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$3.19B
Volume
1.03M
52W Range
$24.10 - $62.53
Target Price
$69.63
Key Metrics Overview
| Market Cap | $3.19B | P/E Ratio | N/A |
| 52W High | $62.53 | 52W Low | $24.10 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -9.6% | 52W Position | 30.9% |
| Overall Score | 40 | Value Score | -- |
| Quality Score | -- | Technical Score | 40 |
Growth Analysis
| EPS Current Est | $-4.79 | EPS Next Est | $-5.24 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRNX | $35.98 | +6.7% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Crinetics Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW